Evidence map›Paper›PMID 17690684›Full record

ArticleGenes and immunity2007

Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.

A Kurylowicz, Y Hiromatsu, B Jurecka-Lubieniecka, D Kula, M Kowalska, M Ichimura, H Koga, H Kaku, E Bar-Andziak, J Nauman and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. The association betweenMolecular biology research communications · 2018
    Article
  6. Article
  7. Review
  8. NF-Journal of immunology research · 2018
    Article
  9. Thyroid-associated Ophthalmopathy.Turkish journal of ophthalmology · 2017
    Review
  10. Association ofWorld journal of diabetes · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The eye and thyroid disease.Current opinion in ophthalmology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

A KurylowiczDepartment of Endocrinology, Medical Research Center, Polish Academy of Science, Warsaw, Poland.
Y Hiromatsu
B Jurecka-Lubieniecka
D Kula
M Kowalska
M Ichimura
H Koga
H Kaku
E Bar-Andziak
J Nauman
B Jarzab
R Ploski
T Bednarczuk
Kurume University · JPThe Maria Sklodowska-Curie National Research Institute of Oncology · PLMedical University of Warsaw · PLPolish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, a functional polymorphism in the NFKB1 gene promoter (-94ins/del ATTG) has been identified and associated with chronic inflammatory diseases. The aim of this study was to analyze the association of NFKB1 polymorphism with susceptibility to and phenotype of Graves' disease (GD). The initial case-control association study, performed in a Polish-Warsaw cohort (388 GD patients and 688 controls), was followed by the two replication studies performed in Polish-Gliwice and Japanese-Kurume cohorts (198 GD patients and 194 controls, and 424 GD patients and 222 controls, respectively). The frequency of the -94del ATTG (D) allele was increased in GD compared to controls in Warsaw cohort. This finding was replicated in Gliwice cohort. Combining both Polish-Caucasian cohorts showed that the NFKB1 polymorphism was significantly associated with susceptibility to GD with a codominant mode of inheritance (P=0.00005; OR=1.37 (1.18-1.60)). No association with GD was found in Japanese cohort. However, subgroup analysis in Japanese GD patients revealed a correlation between the NFKB1genotype and the development of ophthalmopathy (P=0.009; OR=1.49 (1.10-2.01)), and the age of disease onset (P=0.009; OR=1.45 (1.09-1.91)). Our results suggest that NFKB1 -94ins/del ATTG polymorphism may be associated with susceptibility to and/or phenotype of GD.

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticPromoter Regions, GeneticAdultAge FactorsAllelesCase-Control StudiesFemaleGene FrequencyGenotypeGraves DiseaseGraves OphthalmopathyHumansJapanLogistic ModelsMaleNF-kappa B p50 SubunitNFKB1 protein, human

Identifiers

PMID17690684
OpenAlexW2050201332

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.